Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Henry Schein Stock Quote

Henry Schein (NASDAQ: HSIC)

$67.78
(-1.2%)
-$0.82
Price as of May 3, 2024, 4:00 p.m. ET

Henry Schein Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
HSIC -14.34% +7.20% +1.40% +1,420%
S&P +26.26% +74.08% +11.71% +768%

Henry Schein Company Info

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.